SBT IMMUNOTAC
Silverback Therapeutics, Inc.
| Research |
OneLook
Acronym Finder
|
| Serial Number | 87730856 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Attorney Name | Joi A. White |
| Attorney Docket Number | T-4154 US |
| Law Office Assigned | M40 |
| Employee Name | WILSON, MARYNELLE WEST |
Timeline
| 2017-12-21 | Application Filed |
| 2019-01-15 | Published for Opposition |
| 2019-03-12 | Location: INTENT TO USE SECTION |
| 2019-10-14 | Abandon |
| 2019-10-14 | Status: Dead/Abandoned |
| 2019-10-15 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Silverback Therapeutics, Inc. |
| Address | 500 Fairview Avenue North, Suite 600 Seattle DE 98109 |
| Legal Entity Type | Corporation |
| Legal Entity State | DE |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| International Codes: | 42 |
| U.S. Codes: | 100,101 |
| Type Code | Type |
|---|---|
| GS0051 | Therapeutic agents and preparations and biochemicals for use in the treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases and fibrotic diseases; pharmaceuticals and pharmaceutical preparations for use in the treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases and fibrotic diseases; engineered immunomodulatory therapeutic agents and preparations for use in the treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases and fibrotic diseases |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED IN TRAM | 2017-12-25 | 1 NWAP I:Incoming Correspondence |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2018-01-09 | 2 NWOS I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2018-04-02 | 3 DOCK D:Assigned to Examiner |
| PRIORITY ACTION WRITTEN | 2018-04-10 | 4 CPRA R:Renewal |
| PRIORITY ACTION E-MAILED | 2018-04-10 | 5 GPRA F:First Action |
| NOTIFICATION OF PRIORITY ACTION E-MAILED | 2018-04-10 | 6 GPRN O:Outgoing Correspondence |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2018-10-02 | 7 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2018-10-02 | 8 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2018-10-03 | 9 TEME I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2018-10-27 | 10 CNSA P: |
| ASSIGNED TO LIE | 2018-11-10 | 11 ALIE A:Allowance for Publication |
| LETTER OF PROTEST ACCEPTED | 2018-12-12 | 12 LOPT I:Incoming Correspondence |
| LETTER OF PROTEST EVIDENCE REVIEWED-NO FURTHER ACTION TAKEN | 2018-12-13 | 13 LOPR P: |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2018-12-26 | 14 NONP E:E-Mail |
| PUBLISHED FOR OPPOSITION | 2019-01-15 | 15 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2019-01-15 | 16 NPUB E:E-Mail |
| NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2019-03-12 | 17 NOAM E:E-Mail |
| ABANDONMENT - NO USE STATEMENT FILED | 2019-10-14 | 18 ABN6 S: |
| ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | 2019-10-15 | 19 MAB6 E:E-Mail |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 